Lexicon Pharmaceuticals LXRX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 99.5%0.0pp | 99.4%0.0pp | 99.4%+0.2pp | 99.2%+1.1pp | 98%0.0pp | |
| Operating margin | -34.8%+63.4pp | -98.2%-3.8pp | -94.4%+108pp | -202.6%+366pp | -568.6%+65.6pp | |
| Net margin | -37.5%+63.6pp | -101.1%-4.3pp | -96.8%+110pp | -206.4%+362pp | -568%+76.7pp | |
| Returns | ||||||
| Return on equity | -16%+23.7pp | -39.7%+6.2pp | -45.9%+19.4pp | -65.3%+20.8pp | -86.1%+81.6pp | |
| Return on invested capital | -13.5%+20.1pp | -33.5%+4.0pp | -37.5%+15.0pp | -52.5%+23.8pp | -76.3%+32.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.2×-0.1× | 0.3×+0.1× | 0.2×+0.1× | 0.1×0.0× | |
| Liquidity | ||||||
| Current ratio | 18.8×+13.9× | 4.9×-0.8× | 5.6×+1.5× | 4.2×+1.9× | 2.2×-3.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×-0.3× | 0.6×0.0× | 0.5×+0.1× | 0.5×-0.4× | 0.9×+0.1× | |
| Per Share | ||||||
| Book value per share | $0.51+71.1% | $0.30-10.4% | $0.33-7.1% | $0.36+4.8% | $0.34-25.5% | |
| Valuation | ||||||
| Market capitalization | $986.12M+273% | $417.91M-14.8% | $490.59M+75.4% | $279.76M+67.9% | $166.58M-37.6% | |
| Price / sales | 14.2×+5.7× | 8.4×+1.5× | 6.9×+2.1× | 4.8×-0.5× | 5.3×-3.3× | |
| Price / book | 5×+2.8× | 3.9×-0.2× | 4.1×+1.9× | 2.2×+0.8× | 1.4×-0.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Lexicon Pharmaceuticals's profit margins?
- Lexicon Pharmaceuticals (LXRX) runs a 99.5% gross margin and a -34.8% operating margin, with a -37.5% net margin.
- Where do Lexicon Pharmaceuticals's ratios come from?
- Every ratio is computed from Lexicon Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
